From: Beth Asnien McCoy <1

From: Beth Asnien McCoy <1 To: [email protected]> Subject: Leading the charge against neurodegenerative diseases like Alzheimer's Date: Wed, 27 Sep 2017 20:13:03 +0000 EFTA00705224 ;2J Brain Sciences As the world's population ages, neurodegenerative diseases like Alzheimer's, Parkinson's, and others affect more and more people around the world. Few of us have been exempt from the devastating physical and emotional blows patients and their families experience when faced with these debilitating diseases. But at Hebrew University's Edmond and Lily Safra Center for Brain Sciences, researchers are making huge strides in the fight against neurodegenerative disorders: • Early detection breakthrough — A new diagnostic tool developed by . student Suaad Abd-Elhadi allows for earlier detection of Parkinson's giving new hope to those suffering from the disease. • Groundbreaking Alzheimer's drugs — HU Professor Marta Weinstock-Rosin (inventor of Exelon, a drug that improves memory and slows its decline in people with Alzheimer's) has since co-developed a novel neuroprotective drug that blocks EFTA00705225 brain degeneration and memory impairment. She continues to advance the science pushing toward an outright cure. • Revolutionary brain disease treatments — Collaborating with researchers at the startup company TyrNovo, Hebrew University's Dr. Ehud Cohen and Professor Alexander Levitzki found a compound that inhibits the toxic proteins associated with Alzheimer's and other neurodegenerative diseases — an important first step toward finding a cure. Donate now to support Hebrew University researchers continuing to advance the fight against Alzheimer's, Parkinson's and other neurodegenerative diseases. DONATE TODAY One Battery Park Plaza, 25th Floor, New York, NY 10004 www.afhu.org Shop now on AmazonSmile and support AFFIU! ;11Twi ;;;Yo7.11 2,Lin tter ebook agram Tube kedIn FORWARD TO A FRIEND We bsite If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link to update your preferences or unsubscribe. EFTA00705226